Jacques Schrenzel
Jacques Schrenzel (MD) is board-certified in internal medicine, in infectious diseases and in clinical microbiology. He is the co-founder of the Center of Excellence in Bacteriology at the University of Geneva (CEBUG). He is in charge of the bacteriological laboratory and the genomic research laboratory of Geneva University Hospitals (www.genomic.ch). He is recognized for his work on bioinformatics, metagenomics, microarrays and next-generation sequencing techniques, with the common objective to translate new techniques for patient care.
Etienne Ruppé
Dr. Etienne Ruppé is associate professor of bacteriology in the University of Paris and the Bichat-Claude Bernard University teaching Hospital in Paris, France. After graduation as a pharmacist and clinical microbiologist in 2008 (University of Tours and University of Paris Descartes), he spent 4 years as an assistant in the bacteriology laboratory of the Bichat-Claude Bernard University teaching hospital (Pr Antoine Andremont) and obtained his PhD in infectious diseases for his work on the epidemiology of carriage of multidrug-resistant bacteria. He then moved as a post-doc fellow to MetaGenoPolis, INRA (Pr Dusko Ehrlich), to study the resistome of the human gut microbiota. Then, he took a second post-doctoral position in the Genomic Research Laboratory in the Geneva University Hospitals (Pr Jacques Schrenzel) where he worked on the development of clinical metagenomics. He is now associate professor at the University of Paris and the Paris University Hospitals. His current work aims at spanning various aspects of antibiotic resistance: carriage, diagnosis, infections, emergence, epidemiology, prevention and information to the public.
Vladimir Lazaveric
Vladimir Lazarevic is a Researcher at the Geneva University Hospitals (HUG) in Switzerland. He has been developing expertise in genomics, metataxonomics and metagenomics, from sample preparation to data analysis. He has used different NGS methodologies for profiling human oral, skin, respiratory and intestinal microbial communities. He has also been analysing different clinical samples using metagenomics as a tool for pathogen identification.